Jump to Content
ADGC
Alzheimer's Disease
Genetics Consortium
Home
ADGC Core Projects
Contact
About
Program Overview
Members
Committees
Links
Alzheimer's Disease
Acknowledgements
Collaborative Data Access (SAGs)
SAG Proposal Instructions
SAG Overview
Current ADGC Special Analysis Group Projects (SAGs)
Publications
ADGC Publications
Publications Supported by the ADGC
Publications Using ADGC and IGAP Summary Statistics
For Members
Login
You are here
Home
» ADGC Publications
ADGC Publications
Found 6 results
Filters:
Author
is
Shaw, Leslie M
[Clear All Filters]
2019
Dumitrescu L
,
Barnes LL
,
Thambisetty M
,
Beecham G
,
Kunkle B
,
Bush WS
,
Gifford KA
,
Chibnik LB
,
Mukherjee S
,
De Jager PL
et al.
. 2019.
Sex differences in the genetic predictors of Alzheimer's pathology.
.
Brain. 142(9):2581-2589.
2018
Deming Y
,
Dumitrescu L
,
Barnes LL
,
Thambisetty M
,
Kunkle B
,
Gifford KA
,
Bush WS
,
Chibnik LB
,
Mukherjee S
,
De Jager PL
et al.
. 2018.
Sex-specific genetic predictors of Alzheimer's disease biomarkers.
.
Acta Neuropathol. 136(6):857-872.
2017
Deming Y
,
Li Z
,
Kapoor M
,
Harari O
,
Del-Aguila JL
,
Black K
,
Carrell D
,
Cai Y
,
Fernandez MVictoria
,
Budde J
et al.
. 2017.
Genome-wide association study identifies four novel loci associated with Alzheimer's endophenotypes and disease modifiers.
.
Acta Neuropathol. 133(5):839-856.
Chapuis J
,
Flaig A
,
Grenier-Boley B
,
Eysert F
,
Pottiez V
,
Deloison G
,
Vandeputte A
,
Ayral A-M
,
Mendes T
,
Desai S
et al.
. 2017.
Genome-wide, high-content siRNA screening identifies the Alzheimer's genetic risk factor FERMT2 as a major modulator of APP metabolism.
.
Acta Neuropathol. 133(6):955-966.
2014
Toledo JB
,
Van Deerlin VM
,
Lee EB
,
Suh ER
,
Baek Y
,
Robinson JL
,
Xie SX
,
McBride J
,
Wood EM
,
Schuck T
et al.
. 2014.
A platform for discovery: The University of Pennsylvania Integrated Neurodegenerative Disease Biobank.
.
Alzheimers Dement. 10(4):477-484.e1.
2013
Cruchaga C
,
Kauwe JSK
,
Harari O
,
Jin SChih
,
Cai Y
,
Karch CM
,
Benitez BA
,
Jeng AT
,
Skorupa T
,
Carrell D
et al.
. 2013.
GWAS of cerebrospinal fluid tau levels identifies risk variants for Alzheimer's disease.
.
Neuron. 78(2):256-68.